New FDA-approved weight loss drugs like Zepbound are shaking up the market that was once dominated by drugs Ozempic and Wegovy. These aren’t the average weight loss drugs; Dr. Mir Ali, a bariatric surgeon, is amazed at how far the options have come from the once limited choices people had. Meanwhile, Dr. Rashika Bansal, an …
The anxiety of something bad happening to your baby is a genuine fear many parents face. It’s the reason mothers and fathers are glued to their baby monitors or silently entering the nursery to check if their child is breathing. In recent years, it has also meant investing in an infant wearable that provides a …
The approval of an at-home test for chlamydia and gonorrhea by the Food and Drug Administration could lead to earlier detection and treatment amid a growing epidemic in the U.S. However, concerns have arisen about the potential drawbacks of the FDA’s proposal to step up regulation of over-the-counter self-testing of sexually transmitted infections. The surge …
The results of a recent Yahoo News/YouGov poll are shedding light on Americans’ opinions regarding educating children about drugs and training teenagers on how to administer Narcan, the first over-the-counter naloxone nasal spray approved by the Food and Drug Administration. In September, it became available for sale at pharmacies and other retailers for $44.99 for …
By Maggie Fick and Ludwig Burger LONDON (Reuters) – Eli Lilly revealed on Thursday that it has not received the green light in Britain for the injection pen designed for its Mounjaro drug, which is intended for treating obesity and diabetes. This adds a layer of uncertainty to the timing of the product’s debut in …
The 2023-2024 Virus Season: Parents Struggle to Access New RSV Drug The 2023-2024 virus season is the first since the FDA approved a new preventative drug for respiratory syncytial virus (RSV) in infants and toddlers. Although this breakthrough has brought relief to parents, issues such as high demand, supply shortages, and insurance confusion have made …
The 2023-2024 Virus Season: The Challenges of Getting the New RSV Drug The 2023-2024 virus season brings a major breakthrough in the fight against respiratory syncytial virus (RSV), a common childhood illness. The Food and Drug Administration (FDA) has approved a new preventative drug called Nirsevimab, also known as Beyfortus, which aims to protect infants …
RSV Drug Shortages and Insurance Confusion Leave Parents Struggling to Protect Infants The 2023-2024 virus season is the first since the FDA approval of a new preventative drug, Nirsevimab (Beyfortus), for respiratory syncytial virus (RSV) in infants and toddlers. Although this breakthrough has brought relief to parents, the high demand, limited supply, and insurance confusion …
A year ago, few were familiar with the term “Ozempic,” but now, this weight loss drug, along with its similar prescription called Wegovy, is making waves. Originally developed to treat Type 2 diabetes, this injectable medication is being praised as a breakthrough in the fight against obesity. The success of semaglutide, the active ingredient in …
The Food and Drug Administration (FDA) has issued a warning regarding the potential risks associated with the use of ketamine for psychiatric disorders. In an effort to optimize patient safety, the FDA emphasizes that ketamine is not FDA approved for the treatment of any psychiatric disorder. Ketamine, also known as ketamine hydrochloride, falls under the …